Excipient interactions

Excipient Development for Pharmaceutical, Biotechnology, and Drug Delivery Systems

Volumn , Issue , 2006, Pages 93-108

  Moreton, R Christian ^a  

^a Idenix Pharmaceuticals Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84875832830     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (34)

1. Blecher L. The formation of the International Pharmaceutical Excipients Council. Pharm Technol 1991; 15(6): 54, 56.
2. Blecher L. Excipients-the important components. Pharm Process 1995; 12(1): 6-7.
3. Chrzanowski FA, Ulissi LA, Fegely BJ, Newman AC. Preformulation excipient compatibility testing: application of a differential scanning calorimetric method versus a wet granulation simulating, isothermal stress method. Drug Devel Ind Pharm 1986; 12(6): 783-800.
4. Botha SA, Lotter AP. Compatibility study between Naproxen and tablet excipients using differential scanning calorimetry. Drug Dev Ind Pharm 1990; 16(4): 673-683.
5. Foda NH. Compatibility study between Fluvoxamine Maleate, mebeverine hydrochloride and tablet excipients using differential scanning calorimetry. Egypt J Pharm Sci 1992; 33(1-2): 73-81.
6. Wilson RJ, Beezer AE, Mitchell JC. Determination of thermodynamic and kinetic parameters from isothermal heat conduction microcalorimetry: applications to long term reaction studies. J Phys Chem 1996; 99: 7108-7113.
7. Guillory JK, Soon CH, Lach JL. Interactions between pharmaceutical compounds by thermal methods. J Pharm Sci 1969; 58(3): 301-308.
8. Tobyn MJ, McCarthy GP, Staniforth JN, Edge S. Physicochemical comparison between microcrystalline cellulose and silicified microcrystalline cellulose. Int J Pharm 1998; 169: 183-194.
9. Sherwood BE, Hunter EA, Staniforth JN. Pharmaceutical excipient having improved compressibility. US Patent 5,585,115 (1995).
10. Sherwood BE, Becker JW. A new class of high functionality excipients: silicified microcrystalline cellulose. Pharm Tech 1998; 22(10): 78-88.
11. Baichwal AR, Staniforth JN. Directly compressible sustained release excipient. US Patent 4,994,276 (1988).
12. Nail SL, Jiang S, Chongprasert S, Knopp SA. Fundamentals of freeze-drying. Pharm Biotechnol 2002; 14: 281-360.
13. Steele DF, Edge S, Tobyn MJ, Moreton RC, Staniforth JN. Adsorption of an amine drug onto microcrystalline cellulose and silicified microcrystalline cellulose samples. Drug Dev Ind Pharm 2003; 29(4): 475-487.
14. Bolhuis GK, Lerk CF, Zijlstra HT, De Boer AH. Film formation by magnesium stearate during mixing and its effect on tableting. Pharm Weekly 1975; 110(16): 317-325.
15. Johansson ME, Nicklasson N. Investigation of the film formation of magnesium stearate by applying a flow-through dissolution technique. J Pharm Pharmacol 1986; 38: 51-54.
16. Lerk CF, Bolhuis GK, Smedema SS. Interaction of lubricants and colloidal silica during mixing with excipients: I. Its effect on tableting. Pharm Acta Helv 1977; 52(3): 33-39.
17. Lerk CF, Bolhuis GK. Interaction of lubricants and colloidal silica during mixing with excipients: II. Its effect on wettability and dissolution velocity. Pharm Acta Helv 1977; 52(3): 39-44.
18. Timsina MP, Martin GP, Marriott C. Drug delivery to the respiratory tract using dry powder inhalers. Int J Pharm 1994; 101: 1-13.
19. Staniforth JN. Use of hydrogenated vegetable oil as a tablet lubricant. Drug Dev Ind Pharm 1987; 13(7): 1141-1158.
20. Patel N, Kostenbauder HB. Interaction of preservatives with macromolecules I: binding of parahydroxybenzoic acid esters by polyoxyethylene 20 sorbitan monooleate (Tween 80). J Am Pharm Assoc (Sci) 1958; 47: 289-293.
21. Blaug SM, Huang W-T. Interaction of dextroamphetamine sulfate, with dextrates in solution. J Pharm Sci 1973; 62(4): 652-655.
22. Wirth DD, Baertschi SW, Johnson RA, et al. Maillard reaction of lactose and fluoxetine hydrochloride, a secondary amine. J Pharm Sci 1998; 87(1): 31-39.
23. Ahlneck C, Zografi G. The molecular basis of moisture effects on the physical and chemical stability of drugs in the solid state. Int J Pharm 1990; 62: 87-95.
24. Badawy SIF, Gawronski AJ, Alvarez FJ. Application of sorption-desorption moisture transfer modeling to the study of chemical stability of a moisture sensitive drug product in different packaging configurations. Int J Pharm 2001; 223: 1-13.
25. Weiner M, Bernstein IL. Adverse Reactions to Drug Formulation Agents: A Handbook of Excipients. New York: Marcel Dekker, 1989: 93-94.
26. Maquet J, Théveneau H, Djabourov M, Leblond J, Papon P. State of water in gelatin solutions and gels: An 1H n.m.r. investigation. Polymer 1986; 27(7): 1103-1110.
27. Schultze JDR, WaddingtonWA, Ell PJ, Parsons GE, CoffinME, BasitAW. Concentrationdependent effects of polyethylene glycol 400 on gastrointestinal transit and drug absorption. Pharm Res 2003; 20(12): 1984-1988.
28. Dintaman JM, Silverman JA. Inhibition of P-glycoprotein by D-α-tocopheryl polyethylene glycol 1000 succinate (TGPS). Pharm Res 1999; 16: 1550-1556.
29. Monkhouse DC, Lach JL. Drug-excipient interactions. Can J Pharm Sci 1972; 7(2): 29-46.
30. Landín M, Martinez-Pacheco R, Gómez-Amoza JL, Souto C, Concheiro A, Rowe RC. The effect of country of origin on the properties of dicalcium phosphate dihydrate powder. Int J Pharm 1994; 103: 9-18.
31. Jain NK, Rosenberg DB, Ulahannan MJ, Pitchumoni CS. Sorbitol intolerance in adults. Am J Gastroenterol 1985; 80(9): 678-681.
32. Katz M, Poulsen BJ. Corticoid, vehicle and skin interaction in percutaneous absorption. J Soc Cosmet Chem 1972; 23: 565-590.
33. Davis AF, Hadgraft J. Supersaturated solutions as topical drug delivery systems. In: Walters KA, Hadgraft J, eds. Pharmaceutical Skin Penetration Enhancement. New York: Marcel Dekker, 1993: 243-268.
34. Yu L, Bridgers A, Polli J, et al. Vitamin E-TPGS increases absorption flux of an HIV protease inhibitor by enhancing its solubility and permeability. Pharm Res 1999; 16: 1812-1817.